Molecular and Cytogenetic Profiling of Therapy-Related Myeloid Neoplasms (t-MN) versus Primary Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)

被引:0
|
作者
Zhou, Yi Yuan [1 ]
Jajosky, Audrey [2 ]
Sadri, Navid
Beck, Rose [1 ]
机构
[1] Case Western Reserve Univ, Univ Hosp Cleveland, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
1501
引用
收藏
页码:1416 / 1417
页数:2
相关论文
共 50 条
  • [1] Molecular and Cytogenetic Profiling of Therapy-Related Myeloid Neoplasms (t-MN) versus Primary Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)
    Zhou, Yi Yuan
    Jajosky, Audrey
    Sadri, Navid
    Beck, Rose
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1416 - 1417
  • [2] Therapy-related myelodysplastic syndrome (t-MDS) following treatment of acute myeloid leukemia (AML)
    Arana-Yi, C.
    Block, A. W.
    Sait, S. N.
    Ford, L. A.
    Barcos, M.
    Baer, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Risks of therapy-related hematologic neoplasms beyond myelodysplastic syndromes and acute myeloid leukemia
    Dores, Graca M.
    Linet, Martha S.
    Curtis, Rochelle E.
    Morton, Lindsay M.
    BLOOD, 2023, 141 (08) : 951 - 955
  • [4] Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia
    Trost, D
    Hildebrandt, B
    Beier, M
    Müller, N
    Germing, U
    Royer-Pokora, B
    CANCER GENETICS AND CYTOGENETICS, 2006, 165 (01) : 51 - 63
  • [5] Diagnostic of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Germing, Ulrich
    Haferlach, Torsten
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2015, 39 (05): : 291 - 299
  • [6] Azacytidine and Vorinostat in Patients with Chronic Lymphocytic Leukemia (CLL) Diagnosed with Therapy-Related Myelodysplastic Syndromes/Acute Myeloid Leukemia (t-MDS/AML)
    Alvarado, Yesid
    Keating, Michael J.
    O'Brien, Susan
    Kantarjian, Hagop M.
    Wierda, William G.
    Sneed, Troy
    Jain, Nitin
    Garcia-Manero, Guillermo
    BLOOD, 2014, 124 (21)
  • [7] FISH TO INVESTIGATE TET2 INVOLVEMENT IN THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (T-MDS) AND ACUTE MYELOID LEUKEMIA (T-AML)
    Bernasconi, P.
    Dambruoso, I.
    Boni, M.
    Astori, C.
    Zappasodi, P.
    Cavigliano, P. M.
    Giardini, I.
    Rocca, B.
    Zappatore, R.
    Calvello, C.
    Caresana, M.
    Brusamolino, E.
    Castagnola, C.
    Lazzarino, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 24 - 24
  • [8] Therapy-Related Cytopenia of Undetermined Significance (t-CCUS) As a Precursor to Therapy-Related Myeloid Neoplasms (t-MN)
    Shah, Mithun V.
    Mangaonkar, Abhishek A.
    Begna, Kebede H.
    Alkhateeb, Hassan B.
    Greipp, Patricia
    Chen, Dong
    Viswanatha, David S.
    He, Rong
    Elliott, Michelle A.
    Hogan, William J.
    Litzow, Mark R.
    McCullough, Kristen
    Tefferi, Ayalew
    Gangat, Naseema
    Patnaik, Mrinal M.
    Al-Kali, Aref
    BLOOD, 2021, 138
  • [9] CLINICAL CHARACTERISTICS, TREATMENT AND OUTCOMES OF PATIENTS WITH THERAPY-RELATED MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKAEMIA (T-MDS/AML)
    Maung, S.
    Burke, C.
    Hayde, J.
    Desmond, R.
    McHugh, J.
    Enright, H.
    HAEMATOLOGICA, 2015, 100 : 485 - 486
  • [10] CONNECT MDS AND AML: THE MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIA (AML) DISEASE REGISTRY
    Steensma, D.
    Abedi, M.
    Bejar, R.
    Cogle, C.
    Foucar, K.
    Garcia-Manero, G.
    George, T.
    Grinblatt, D.
    Komrokji, R.
    Maciejewski, J.
    Pollyea, D.
    Roboz, G.
    Savona, M.
    Scott, B.
    Sekeres, M.
    Thompson, M.
    Sugrue, M.
    Swern, A.
    Nifenecker, M.
    Erba, H.
    LEUKEMIA RESEARCH, 2015, 39 : S124 - S124